PATENT CLAIM ANALYSIS

Application Number: 16125124
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "319000"]

Abstract:
The disclosure generally relates to pharmaceutical compositions including a benzhydrylsulfinylacetamide antidepressant and an amount of sodium chloride effective to increase a mean arterial blood pressure of a subject and methods for ameliorating symptoms of dementia including forms of dementia diagnosed as Alzheimer's disease and side-effects associated with the administration of cognition effecting pharmaceuticals.

Claim (Index 5):
The pharmaceutical composition of  claim 1 , wherein the benzhydrylsulfinylacetamide wakefulness promoting agent has the formula wherein X 1  and X 2  may be the same or different, and are H, Cl, or F; Z 1  and Z 2  are the same or different and are H, \u2014CH 3 , \u2014CH(CH 3 ) 2 , or \u2014C(CH 3 ) 3 , with the proviso that at least one Z 1  and Z 2  is H, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 97.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15409775', '15409655', '16090142', '12689957', '16119439']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6984310922100678
- 35 USC 102 Novelty (BERT): 0.510057760552287
- Combined Prediction Score: 0.6795937590442898
- Mean Citation Score: 188.03500000000005
- Max Citation Score: 198.47554
- Similarity Product: 121.3685784155345

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test